FDA inspection
Hyphen BioMed sasu: FDA inspection ending Jun 20, 2012
FDA inspection 788357 · Official Action Indicated (OAI) · Neuville-Sur-Oise
Key facts
| Inspection ID | 788357 |
|---|---|
| Firm | Hyphen BioMed sasu |
| FEI number | 3004434070 |
| Address | 155 rue d Eragny |
| City | Neuville-Sur-Oise |
| Country | France |
| Fiscal year | 2012 |
| Inspection end date | Jun 20, 2012 |
| Classification | Official Action Indicated (OAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
| Warning letter | 335758 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data